Bill Morrison
Bill Morrison represents national healthcare providers in a range of litigation and compliance matters involving government enforcement, internal investigation, False Claims Act cases, and antitrust counseling. A former senior in-house lawyer at one of the nation’s largest public healthcare companies, Bill understands the burden litigation and investigations can have on in-house counsel and in-house business units. He has the hands-on experience to efficiently and successfully defend corporations and executives in complex healthcare matters while minimizing disruption to their businesses.
Bill has led teams that have handled many mission-critical matters, such as defending:
- A behavioral healthcare management company against claims of violating the Racketeer Influenced and Corrupt Organizations (RICO) Act and the Rehabilitation Act
- A chief executive officer and general counsel of a healthcare client in dozens of cases, spanning Arizona, Florida, Kentucky, and New Mexico, alleging that the firm’s clients breached their fiduciary duties
In addition to his own practice, Bill is co-chair of the firm’s Healthcare and Life Sciences Practice Group, helping to manage a growing team of more than two dozen lawyers nationwide who advise clients across all sectors of the healthcare industry on business transactions, regulatory compliance, government investigations, patent litigation and counseling, as well as a host of issues arising from the COVID-19 pandemic. The group collaborates closely with our Precision Medicine and Digital Health Practice Group to counsel corporations, technology startups, non-profit research institutions, universities, hospital systems, pharmaceuticals, and investors supporting the industry.
Bill returned to the firm in 2019 after serving as the vice president and assistant general counsel at Tenet Healthcare Corporation, where he was responsible for the regulatory group, civil and criminal government investigations and litigation, False Claims Act litigation, complex litigation, cyber incident response, and malpractice litigation.
Bill regularly writes and speaks on cutting-edge topics relevant to the healthcare industry, including the impact of the COVID-19 pandemic. He also is active in pro bono and community activities, including serving as chair of Dallas Afterschool, and having held leadership roles for the United Way of Metropolitan Dallas and Educate Dallas.
- Represented healthcare group purchasing organization in connection with civil and criminal investigations by the U.S. Attorney's Office (N.D. Tex.) and U.S. Department of Health and Human Services Office of Inspector General into alleged violations of anti-kickback statute.
- Represented former national sales director of an orthopedic spine company in federal civil and criminal investigation by U.S. Attorney's Office (N.D. Tex.) into alleged payment of kickbacks to physicians to induce use of company's surgical devices.
- Represented SCCI in the False Claims Act action filed by six relators alleging false claims for payment related to the admission and continued hospitalization of patients in a long-term acute care facility. The AUSA declined to intervene and the action was partially unsealed for the purpose of settlement.
- Represented one of the nation's largest healthcare providers in an internal investigation of allegations of potential submission of false claims in the cardiac catheterizations laboratory. The investigation included a review of medical records to analyze quality of care issues. Advised client on voluntary disclosure issues.
- Advised and counseled one of the nation's largest healthcare providers in the self-disclosure of overpayments for excluded employees. Negotiated settlement with the Department of Justice and HHS OIG on behalf of client.
- United Way of Metropolitan Dallas, Board of Directors, Governance Chair, 2008-2018
- Educate Dallas, Former Chair of the Board of Directors, 2012- 2018
- Dallas Afterschool, Member of the Board of Directors, 2017- Present
- Law360 Healthcare Editorial Board, Former Member
- “False Claims Act Year in Review,” speaker, Dallas Bar Association Health Law Section, February 21, 2024.
- “False Claims Act: 2022 Year in Review,” speaker, Practising Law Institute 1-Hour Program, January 26, 2023.
- “False Claims Act Year in Review,” speaker, Dallas Bar Association Health Law Section, January 18, 2023.
- “Lessons Learned from the Paycheck Protection Program: What Businesses Need to Know About Federal Grants and Loans,” speaker, State Bar of Texas 20th Annual Course on Advanced Business Law, November 4, 2022.
- “Government Using Big Data and Agency Coordination in Reinvigorated Focus on Prosecuting Widespread Pandemic Fraud,” co-author, Pratt’s Government Contracting Law Report, August 2022.
- "You Have the Money, Now Don’t Get Prosecuted: Government Grants and Loan Programs During the Pandemic," presenter, Texas Bar CLE: 19th Annual Course Advanced Business Law, Houston, Texas, November 5, 2021.
- “Mitigating False Claims Act Liability Risks for Healthcare Recipients of COVID-19 Funding,” speaker, Strafford CLE webinar, March 24, 2021.
- “Trends in Telehealth Fraud Enforcement During the COVID-19 Pandemic,” co-author, PLI Chronicle: Insights and Perspectives for the Legal Community, February 2021.
- “False Claims Act 2020 Year in Review,” speaker, Dallas Bar Association Health Law Section, January 20, 2021.
- False Claims Act: 2020 Year in Review, co-presenter, Practising Law Institute 1-Hour Program, January 2021.
- “The Risk of False Claims Act Liability for Recipients of COVID-19 Funding,” co-presenter, Practising Law Institute 1-Hour Program
- "2019 False Claims Act Year In Review," co-presenter, Dallas Bar Association Health Law Section.
Education
J.D., University of Oklahoma College of Law, 1998, Order of the Barristers
B.S., Baylor University, 1995
Admissions
Texas
Haynes and Boone, LLP Partner Bill Morrison was quoted in a MarketWatch article after shares of Ticketmaster parent Live Nation Entertainment Inc. slid on Tuesday, following reports that it could soon be hit by a government antitrust lawsuit. "Based on the uproar around the country on ticket prices, you would assume that this case would focus on Live Nation's ticketing practices and the use of its [...]
